Imodium
Identification
- Brand Name
- Imodium
- Product Description
- Imodium is an over-the-counter opioid agonist available in multiple countries including the United States, Canada, Germany, Colombia, Italy, and Indonesia. It was first marketed in 1983. It is available in an Oral Capsule, an Oral Tablet, and an Oral Solution. It contains one active ingredient: Loperamide, in its salt form Loperamide hydrochloride. Loperamide is a medication used to treat diarrhea.
- Ingredients
Drug Salt Loperamide Loperamide hydrochloride
Pharmacology
- Indications
- Symptomatic treatment of Diarrhea PrescriptionSymptomatic treatment of Traveler's Diarrhea OTC Use
- Products
Dosage Strength Route Labeller Marketing Start Marketing End NDC Code Capsule, coated 2 mg Oral JANSSEN CILAG S.A. 2007-01-02 2016-07-17 Colombia INVIMA 2006M-007325-R2 Capsule 2 mg/1 Oral McNeil Consumer Healthcare 2008-02-26 - US 50458-400 Capsule, liquid filled 2 mg/1 Oral Johnson & Johnson Consumer Inc. 2016-07-11 - US 50580-367 Tablet, film coated 2 mg/1 Oral Johnson & Johnson Consumer Inc. 2015-07-13 - US 50580-317 Tablet 2.152 mg Oral Janssen Cilag, S. A. De C. V. 1968-01-01 - Mexico 83335:1 Solution 1 mg/7.5mL Oral Johnson & Johnson Consumer Inc. 2004-07-01 - US 50580-134 Capsule 2 mg Oral JOHNSON & JOHNSON PTE. LTD. 1991-08-05 - Singapore SIN06212P Capsule 2 mg Oral 2006-04-01 - Germany 02334188 Capsule 2 mg Oral 2006-04-01 - Germany 01869444 Capsule 2 mg / cap Oral Janssen Pharmaceutica, Division Of Janssen Ortho Inc. 1983-12-31 1997-07-03 Canada 00579343 Tablet 2 mg / tab Oral Janssen Pharmaceutica, Division Of Janssen Ortho Inc. 1990-12-31 1999-06-16 Canada 00860743 Tablet 2 mg Oral Mcneil Consumer Healthcare Division Of Johnson & Johnson Inc 1996-09-09 2014-05-06 Canada 02183862 Tablet, film coated Oral 2016-03-22 - Indonesia DKL1124401917A1 Tablet, film coated 2 mg/1 Oral REMEDYREPACK INC. 2015-10-13 2016-12-24 US 61786-439 Tablet, chewable 2 mg/1 Oral Mc Neil Consumer Healthcare Div. Mc Neil Ppc, Inc 2007-02-01 2013-10-31 US 50580-397 Tablet 2 mg/1 Oral Mc Neil Consumer Healthcare Div. Mc Neil Ppc, Inc 1989-12-01 2014-12-31 US 50580-295
Interactions
- Drug Interaction Search
- Warning: If no interactions are found between two drugs, it does not necessarily mean that no interactions exist. Always consult with a healthcare professional.This interaction checker is limited to 5 drugs at once, available for educational and information purposes only. It is not representative of the full commercial version, which integrates into your products. Learn more
- All Drug Interactions
- Show all
Drug Interaction Integrate drug-drug
interactions in your softwareAbametapir The serum concentration of Loperamide can be increased when it is combined with Abametapir. Abatacept The metabolism of Loperamide can be increased when combined with Abatacept. Abemaciclib The serum concentration of Abemaciclib can be increased when it is combined with Loperamide. Abiraterone The metabolism of Loperamide can be decreased when combined with Abiraterone. Abrocitinib The excretion of Loperamide can be decreased when combined with Abrocitinib. Acebutolol Loperamide may increase the arrhythmogenic activities of Acebutolol. Aceclofenac The risk or severity of hyperkalemia can be increased when Loperamide is combined with Aceclofenac. Acemetacin The risk or severity of hyperkalemia can be increased when Loperamide is combined with Acemetacin. Acetyldigitoxin Acetyldigitoxin may increase the arrhythmogenic activities of Loperamide. Acetylsalicylic acid The risk or severity of hyperkalemia can be increased when Loperamide is combined with Acetylsalicylic acid. Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more